Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer

Abstract

Knowledge on the molecular mechanisms underlying metastasis colonization in Non-Small Cell Lung Cancer (NSCLC) remains incomplete. A complete overview integrating driver mutations, primary tumour heterogeneity and overt metastasis lacks the dynamic contribution of disseminating metastatic cells due to the inaccessibility to the molecular profiling of Circulating Tumour Cells (CTCs). By combining immunoisolation and whole genome amplification, we performed a global gene expression analysis of EpCAM positive CTCs from advanced NSCLC patients. We identified an EpCAM+ CTC-specific expression profile in NSCLC patients mostly associated with cellular movement, cell adhesion and cell-to-cell signalling mediated by PI3K/AKT, ERK1/2 and NF-kB pathways. NOTCH1 emerged as a driver connecting active signalling pathways, with a reduced number of related candidate genes (NOTCH1, PTP4A3, LGALS3 and ITGB3) being further validated by RT-qPCR on an independent cohort of NSCLC patients. In addition, these markers demonstrated high prognostic value for Progression-Free Survival (PFS). In conclusion, molecular characterization of EpCAM+ CTCs from advanced NSCLC patients provided with highly specific biomarkers with potential applicability as a “liquid biopsy” for monitoring of NSCLC patients and confirmed NOTCH1 as a potential therapeutic target to block lung cancer dissemination.

Circular RNAs play an important role in late-stage gastric cancer: Circular RNA expression profiles and bioinformatics analyses

“…NOTCH1 has emerged as a driver connecting active signaling pathways, providing a potential therapeutic target for lung cancer transmission. 41 Recent studies have demonstrated that the human NOTCH1 gene is involved in metastasis and cancer stem cell maintenance.…”

Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients

“…With this panel we evaluated critical steps and characteristics considered highly relevant for prostate CTCs biology [ 19 , 20 ]. With this approach, previously validated in colorectal, endometrial and lung cancer [ 21 – 23 ], we identified a panel of biomarkers with demonstrated prognostic significance for progression free survival (PFS) and OS in mCRPC under taxane treatment.…”

The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

“…Hypoxia or overexpression of HIF-1α induces the EMT via NF-κB in pancreatic cancer cells [70] and inhibition of NF-κB deregulates EMT [71] Promotes PCa cell survival, tumor invasion, metastasis, and chemoresistance [72,73] NSCLC-CTC gene expression profile was associated with cellular movement, cell adhesion and differentiation, and cell-tocell signaling linked to PI3K/AKT, ERK1/2, and NF-κβ pathways [74]. No report in PCa CTCs…”